Editor:
Outflow failure is attributed mostly to mechanical problems such as catheter migration, omental wrapping, constipation, and intraluminal obstruction with fibrin or clot; and it usually occurs shortly after initiation of peritoneal dialysis (PD). Fracture or rupture of the PD catheter is, however, a very unusual cause of drainage failure. We recently experienced a case of early drainage failure because of silicone PD catheter fracture, without previous mechanical or chemical injury, that occurred 1 month after initiation of PD.
A 62-year-old man visited our PD center because of drainage failure. Because of diabetic end-stage renal disease, a silicone rubber double-cuffed straight Tenckhoff catheter had been successfully inserted without complication a month earlier [ Figure 1(A) ]. Seven days before presentation, the patient had sensed something abruptly protruding in the abdomen, and subsequently, infused fluid was not being drained. He became swollen and complained of fullness in the abdomen because of drainage failure after repeated exchanges. Hernia was suspected at first, but no palpable mass in the abdomen or edema of the scrotum was observed. The exit site was clear, and no abnormal break was seen in the catheter outside the exit site. During the month after PD initiation, exit-site care was performed with povidone iodine without use of mupirocin ointment, and peritonitis did not occur. Surprisingly, abdominal radiography revealed a clear break of the PD catheter in the subcutaneous area [ Figure 1 (B)].
The catheter was removed immediately, and a new catheter was inserted at the same time. The fracture site was found to be located just distal to the internal cuff embedded in the rectus muscle in the operating field
To date, several reports on this rare complication have been published. Most instances are external breaks associated with mechanical or chemical stress (1) (2) (3) . Internal breaks are relatively uncommon, but they can be caused by product defects, accidental needle-stick injury, the catheter becoming brittle with aging, and the intrinsic properties of polyurethane (4) (5) (6) (7) (8) . In particular, it has been widely accepted that polyurethane catheters are highly biocompatible, but vulnerable to various types of physical and chemical stress that lead to polyurethane degradation (7, 8) . Moreover, Weaver et al. (9) reported that mupirocin containing polyethylene glycol causes structural changes in PD catheters and that the resulting abnormalities increase in severity with longer duration of mupirocin use. It can therefore be speculated that, together, such factors lead to weakening and softening of catheter, eventually resulting in fracture or rupture.
In our patient, however, a polyurethane-based catheter was not used, and mupirocin ointment had never been applied. Catheter aging was unlikely because the drainage failure occurred 1 month after initiation of PD. The patient also denied traumatic accident or strong hand manipulation. We speculate that a defective silicone catheter escaping quality control checks in the production line might lose resistance to mechanical strain. Relevant to our assumption is a prior report by Panuccio et al. (2) of 5 episodes in 4 patients of "epidemic" spontaneous catheter rupture. They suspected a problem with defective silicone catheters during the manufacturing process because no definite cause for the fractures could be found, and most ruptures occurred at similar sites shortly after initiation of PD. Alternatively, damage to the catheter at the time of insertion, such as We present the clinical case of a 72-year-old woman who was diagnosed with type 1 diabetes when she was 30 [characterized by presentation before the age of 35 years in the absence of obesity, with sudden onset and a need for insulin treatment at onset (1)]. Her disease was associated with diabetic retinopathy, treated by laser, and microangiopathic complications, with amputation of toes in the right foot. She developed chronic kidney disease, probably in relation to the diabetes and the associated vascular disease, with very poor glycemic control using subcutaneous insulin in the pre-dialysis period.
This woman required renal replacement therapy because clinical symptoms of uremia and serum urea 6.32 mg/dL and creatinine 275 mg/dL. She chose continuous ambulatory peritoneal dialysis (CAPD), beginning treatment 15 years before the time of the present report. Her treatment began with an incremental CAPD regime of 2 -3 daily exchanges and a volume of 1.5 -2 L per exchange. In the beginning, she had a glomerular filtration rate of 7.3 mL/min, and she maintained residual renal function (RRF) of about 6.46 -14.6 mL/ min over the years. Her mean of residual renal function was 10.8 mL/min (Table 1) , and her weekly Kt/V never fell below 2.4, nor her weekly creatinine clearance below 120 L/1.73 m 2 . During the course of her treatment, her dialysate-to-plasma creatinine was maintained at about 0.59 -0.72, with fairly constant peritoneal protein losses (Table 1) . Table 1 shows the remaining adequacy parameters for this patient.
During her follow-up, the patient had 4 episodes of peritonitis. In most of those infections, good results were obtained with intraperitoneal antibiotics. In 1 episode, resolution of effluent turbidity required removal and replacement of the peritoneal catheter, a unique occurrence during her 15 years on therapy. Her 4 hospitalizations during those 15 years included 2 for peritonitis, 1 for replacement of the peritoneal catheter, and 1 for an umbilical hernia surgery. Her retinopathy stabilized at the same visual acuity during follow-up.
From the onset of CAPD, the excellent blood pressure control that this woman achieved eliminated her need --GFR = glomerular filtration rate; CCr = creatinine clearance; BSA = body surface area; nPCR = normalized protein catabolic rate; D/P Cr = dialysate-to-plasma ratio of creatinine; PPL = peritoneal protein losses; HA = high average transport; LA = low average transport.
